Truist Financial’s Dianthus Therapeutics DNTH Stock Holding History

Truist Financial’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	3,779 +364	+11%	+$31.8K	﹤0.01%	2415
2026 Q1	$287K	Buy	+3,415	New	+$198K	﹤0.01%	2418
2022 Q1	–	Sell	-7,989	Closed	-$566K	–	2713
2021 Q4	$566K	Buy	7,989 +125	+2%	+$12.6K	﹤0.01%	1937
2021 Q3	$916K	Buy	7,864 +456	+6%	+$53.1K	﹤0.01%	1664
2021 Q2	$1.16M	Buy	7,408 +482	+7%	+$88.5K	﹤0.01%	1552
2021 Q1	$1.31M	Sell	6,926 -1,344	-16%	-$226K	﹤0.01%	1432
2020 Q4	$1.04M	Buy	8,270 +187	+2%	+$21.2K	﹤0.01%	1456
2020 Q3	$879K	Buy	8,083 +2,718	+51%	+$322K	﹤0.01%	1430
2020 Q2	$645K	Buy	5,365 +1,475	+38%	+$208K	﹤0.01%	1492
2020 Q1	$391K	Buy	3,890 +2,946	+312%	+$546K	﹤0.01%	1697
2019 Q4	$229K	Buy	+944	New	+$176K	﹤0.01%	2293

Other funds holding DNTH

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

PFA

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Truist Financial's DNTH Position: Q2 2026 in Review

Truist Financial increased its Dianthus Therapeutics (DNTH) stake by 11% in Q2 2026, buying an estimated $31.8K and bringing the position to 3,779 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

Truist Financial first reported a position in DNTH in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.31M in Q1 2021. 33 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Truist Financial held 3,779 shares of Dianthus Therapeutics worth $368K as of Q2 2026.
Truist Financial bought 364 Dianthus Therapeutics shares in Q2 2026, an estimated $31.8K.
Dianthus Therapeutics made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2415 holding.
Truist Financial first reported a position in Dianthus Therapeutics in Q4 2019 and has held it in 11 quarters since.
Truist Financial's Dianthus Therapeutics position peaked at $1.31M in Q1 2021.
33 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.